In April 2026, a review article was published from Italian haematologists titled, ‘Modern and multidisciplinary care in polycythemia vera’ (PV).
Fig. 1 The four “must-dos” in polycythemia vera patients
The authors “propose that a transdisciplinary approach be adopted throughout the diagnostic and therapeutic continuum for PV to optimize patient outcomes. The review also proposes a novel cytoreductive treatment algorithm in PV going beyond the conventional risk stratification based on patient’s age and history of thrombosis but rather focusing on patient’s characteristics and treatment needs. Finally, we examine ongoing clinical studies and the latest results and insights on PV therapies (including the JAK inhibitor ruxolitinib, the next-generation mono-pegylated type I interferon ropeginterferon alfa-2b, the iron metabolism modifiers and other experimental approaches) that could reshape the standard of care in PV.”
Fig. 2 Multidisciplinary assessment of all patients with PV
Fig. 3 Multidisciplinary assessments for patients with PV in specific clinical contexts.
The full article is available to read in full if you click on the PDF at the link.
